Discounted Cash Flow
GSK Plc. ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $27.9b | $912.0m | $1.6b | 3.3% | $0.19 |
| 2017 | $30.2b (8.2%) | $1.5b (68.0%) | $6.9b (330.0%) | 5.1% (55.2%) | $0.31 (67.0%) |
| 2018 | $30.8b (2.1%) | $3.6b (136.5%) | $8.4b (21.7%) | 11.8% (131.6%) | $0.74 (134.7%) |
| 2019 | $33.8b (9.5%) | $4.6b (28.2%) | $8.0b (-4.8%) | 13.8% (17.1%) | $0.94 (27.4%) |
| 2020 | $34.1b (1.0%) | $5.7b (23.8%) | $8.4b (5.2%) | 16.9% (22.5%) | $1.16 (23.0%) |
| 2021 | $34.1b (0.0%) | $4.4b (-23.7%) | $8.0b (-5.8%) | 12.9% (-23.8%) | $0.88 (-24.2%) |
| 2022 | $29.3b (-14.0%) | $15.0b (241.1%) | $5.1b (-35.3%) | 51.0% (296.8%) | $3.71 (324.0%) |
| 2023 | $30.3b (3.4%) | $4.9b (-67.1%) | $4.4b (-14.0%) | 16.2% (-68.1%) | $1.22 (-67.3%) |
| 2024 | $31.4b (3.5%) | $2.6b (-47.7%) | $3.6b (-19.3%) | 8.2% (-49.5%) | $0.63 (-48.0%) |
| 2025 | $32.7b (4.1%) | $5.7b (122.0%) | $6.4b (78.2%) | 17.5% (113.2%) | $1.41 (123.3%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.